|
1
|
Consensus nomenclature for in vivo imaging of reversibly binding radioligands.
|
J Cereb Blood Flow Metab
|
2007
|
11.79
|
|
2
|
Inverse consistent mapping in 3D deformable image registration: its construction and statistical properties.
|
Inf Process Med Imaging
|
2005
|
2.87
|
|
3
|
Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.
|
Am J Geriatr Psychiatry
|
2002
|
2.80
|
|
4
|
Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study.
|
J Cereb Blood Flow Metab
|
2005
|
2.52
|
|
5
|
Tight glycemic control increases metabolic distress in traumatic brain injury: a randomized controlled within-subjects trial.
|
Crit Care Med
|
2012
|
1.62
|
|
6
|
Estimation of the 18F-FDG input function in mice by use of dynamic small-animal PET and minimal blood sample data.
|
J Nucl Med
|
2007
|
1.42
|
|
7
|
Serotonin 1A receptors in the living brain of Alzheimer's disease patients.
|
Proc Natl Acad Sci U S A
|
2006
|
1.34
|
|
8
|
Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice.
|
J Nucl Med
|
2011
|
1.31
|
|
9
|
In vivo quantitation of glucose metabolism in mice using small-animal PET and a microfluidic device.
|
J Nucl Med
|
2007
|
1.30
|
|
10
|
Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.
|
Arch Gen Psychiatry
|
2002
|
1.30
|
|
11
|
18F-fluorothymidine kinetics of malignant brain tumors.
|
Eur J Nucl Med Mol Imaging
|
2007
|
1.25
|
|
12
|
1-11C-acetate kinetics of prostate cancer.
|
J Nucl Med
|
2008
|
1.20
|
|
13
|
Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest.
|
J Nucl Med
|
2011
|
1.18
|
|
14
|
18F-FDOPA kinetics in brain tumors.
|
J Nucl Med
|
2007
|
1.18
|
|
15
|
Noninvasive measurement of myocardial activity concentrations and perfusion defect sizes in rats with a new small-animal positron emission tomograph.
|
Circulation
|
2002
|
1.18
|
|
16
|
Quantification of cerebral glucose metabolic rate in mice using 18F-FDG and small-animal PET.
|
J Nucl Med
|
2009
|
1.17
|
|
17
|
Noninvasive measurement of cardiovascular function in mice with high-temporal-resolution small-animal PET.
|
J Nucl Med
|
2006
|
1.14
|
|
18
|
Accuracy of a method using short inhalation of (15)O-O(2) for measuring cerebral oxygen extraction fraction with PET in healthy humans.
|
J Nucl Med
|
2004
|
1.13
|
|
19
|
Selective metabolic reduction in gray matter acutely following human traumatic brain injury.
|
J Neurotrauma
|
2004
|
1.09
|
|
20
|
Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region.
|
Eur J Nucl Med Mol Imaging
|
2009
|
1.08
|
|
21
|
Dynamic PET/CT with 11C-acetate in prostate cancer.
|
J Nucl Med
|
2012
|
1.06
|
|
22
|
Improved parametric image generation using spatial-temporal analysis of dynamic PET studies.
|
Neuroimage
|
2002
|
1.04
|
|
23
|
Functional expression of SGLTs in rat brain.
|
Am J Physiol Cell Physiol
|
2010
|
1.04
|
|
24
|
Unexpected expression pattern for glycosylphosphatidylinositol-anchored HDL-binding protein 1 (GPIHBP1) in mouse tissues revealed by positron emission tomography scanning.
|
J Biol Chem
|
2010
|
1.03
|
|
25
|
Kinetics of 3'-deoxy-3'-18F-fluorothymidine during treatment monitoring of recurrent high-grade glioma.
|
J Nucl Med
|
2010
|
1.02
|
|
26
|
Visualizing pathology deposits in the living brain of patients with Alzheimer's disease.
|
Methods Enzymol
|
2006
|
1.02
|
|
27
|
Movement correction method for human brain PET images: application to quantitative analysis of dynamic 18F-FDDNP scans.
|
J Nucl Med
|
2010
|
1.01
|
|
28
|
Correlation of regional metabolic rates of glucose with glasgow coma scale after traumatic brain injury.
|
J Nucl Med
|
2003
|
1.01
|
|
29
|
Acute changes in regional cerebral (18)F-FDG kinetics in patients with traumatic brain injury.
|
J Nucl Med
|
2004
|
1.01
|
|
30
|
Derivation of a compartmental model for quantifying 64Cu-DOTA-RGD kinetics in tumor-bearing mice.
|
J Nucl Med
|
2009
|
0.99
|
|
31
|
Dissecting molecular mechanisms in the living brain of dementia patients.
|
Acc Chem Res
|
2009
|
0.98
|
|
32
|
Subcortical white matter metabolic changes remote from focal hemorrhagic lesions suggest diffuse injury after human traumatic brain injury.
|
Neurosurgery
|
2004
|
0.97
|
|
33
|
Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.
|
Am J Geriatr Psychiatry
|
2009
|
0.97
|
|
34
|
Imaging beta-amyloid fibrils in Alzheimer's disease: a critical analysis through simulation of amyloid fibril polymerization.
|
Nucl Med Biol
|
2005
|
0.94
|
|
35
|
Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease.
|
Arch Gen Psychiatry
|
2006
|
0.94
|
|
36
|
PET of brain prion protein amyloid in Gerstmann-Sträussler-Scheinker disease.
|
Brain Pathol
|
2009
|
0.93
|
|
37
|
PET imaging of neuropathology in tauopathies: progressive supranuclear palsy.
|
J Alzheimers Dis
|
2013
|
0.91
|
|
38
|
Semiautomated analysis of small-animal PET data.
|
J Nucl Med
|
2006
|
0.91
|
|
39
|
Amyloid-β positron emission tomography imaging probes: a critical review.
|
J Alzheimers Dis
|
2013
|
0.90
|
|
40
|
PPARγ silencing enhances osteogenic differentiation of human adipose-derived mesenchymal stem cells.
|
J Cell Mol Med
|
2013
|
0.88
|
|
41
|
Influence of dietary state and insulin on myocardial, skeletal muscle and brain [F]-fluorodeoxyglucose kinetics in mice.
|
EJNMMI Res
|
2011
|
0.88
|
|
42
|
Redefining the pericontusional penumbra following traumatic brain injury: evidence of deteriorating metabolic derangements based on positron emission tomography.
|
J Neurotrauma
|
2013
|
0.87
|
|
43
|
2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease.
|
Mol Imaging Biol
|
2003
|
0.87
|
|
44
|
Discriminant analysis of ¹⁸F-fluorothymidine kinetic parameters to predict survival in patients with recurrent high-grade glioma.
|
Clin Cancer Res
|
2011
|
0.87
|
|
45
|
[F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: effects of aging, in vivo blockade, and anti-Aβ antibody treatment.
|
Neurobiol Dis
|
2011
|
0.85
|
|
46
|
Regional distribution of SGLT activity in rat brain in vivo.
|
Am J Physiol Cell Physiol
|
2012
|
0.83
|
|
47
|
Positron emission tomography imaging of DMBA/TPA mouse skin multi-step tumorigenesis.
|
Mol Oncol
|
2010
|
0.82
|
|
48
|
In vivo brain imaging of tangle burden in humans.
|
J Mol Neurosci
|
2002
|
0.82
|
|
49
|
Measurement of the global lumped constant for 2-deoxy-2-[18F]fluoro-D-glucose in normal human brain using [15O]water and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography imaging. A method with validation based on multiple methodologies.
|
Mol Imaging Biol
|
2003
|
0.81
|
|
50
|
Exploring a mathematical model for the kinetics of beta-amyloid molecular imaging probes through a critical analysis of plaque pathology.
|
Mol Imaging Biol
|
2006
|
0.81
|
|
51
|
Automated VOI Analysis in FDDNP PET Using Structural Warping: Validation through Classification of Alzheimer's Disease Patients.
|
Int J Alzheimers Dis
|
2012
|
0.80
|
|
52
|
A hybrid clustering method for ROI delineation in small-animal dynamic PET images: application to the automatic estimation of FDG input functions.
|
IEEE Trans Inf Technol Biomed
|
2010
|
0.80
|
|
53
|
Titration of variant HSV1-tk gene expression to determine the sensitivity of 18F-FHBG PET imaging in a prostate tumor.
|
J Nucl Med
|
2009
|
0.80
|
|
54
|
Postmortem 3-D brain hemisphere cortical tau and amyloid-β pathology mapping and quantification as a validation method of neuropathology imaging.
|
J Alzheimers Dis
|
2013
|
0.80
|
|
55
|
A study of non-invasive Patlak quantification for whole-body dynamic FDG-PET studies of mice.
|
Biomed Signal Process Control
|
2012
|
0.79
|
|
56
|
Prediction of cognitive decline based on hemispheric cortical surface maps of FDDNP PET.
|
Neuroimage
|
2012
|
0.79
|
|
57
|
Clustering-based linear least square fitting method for generation of parametric images in dynamic FDG PET studies.
|
Int J Biomed Imaging
|
2007
|
0.79
|
|
58
|
¹⁸F-FLT and ¹⁸F-FDOPA PET kinetics in recurrent brain tumors.
|
Eur J Nucl Med Mol Imaging
|
2014
|
0.78
|
|
59
|
Improved derivation of input function in dynamic mouse [18F]FDG PET using bladder radioactivity kinetics.
|
Mol Imaging Biol
|
2013
|
0.77
|
|
60
|
The role of dose distribution gradient in the observed ferric ion diffusion time scale in MRI-Fricke-infused gel dosimetry.
|
Magn Reson Imaging
|
2002
|
0.76
|
|
61
|
Blood flow, flow reserve, and glucose utilization in viable and nonviable myocardium in patients with ischemic cardiomyopathy.
|
Eur J Nucl Med Mol Imaging
|
2013
|
0.75
|
|
62
|
Comparative evaluation of Logan and relative-equilibrium graphical methods for parametric imaging of dynamic [18F]FDDNP PET determinations.
|
Neuroimage
|
2011
|
0.75
|
|
63
|
Role of Kinetic Modeling in Biomedical Imaging.
|
J Med Sci
|
2008
|
0.75
|
|
64
|
Study of an image-derived SUV and a modified SUV using mouse FDG-PET.
|
Nucl Med Biol
|
2010
|
0.75
|
|
65
|
A least-squares error minimization approach in the determination of ferric ion diffusion coefficient of Fricke-infused dosimeter gels.
|
Med Phys
|
2005
|
0.75
|
|
66
|
Isotropic three-dimensional MRI-Fricke-infused gel dosimetry.
|
Med Phys
|
2013
|
0.75
|
|
67
|
An image-based approach to measure the ferric ion diffusion coefficient in fricke gel dosimetry.
|
Conf Proc IEEE Eng Med Biol Soc
|
2005
|
0.75
|